Advertisement
News
Advertisement

Meridian Bioscience says FDA clears bacterium test

Tue, 07/13/2010 - 12:45pm
The Associated Press

Meridian Bioscience Inc. said Tuesday that the Food and Drug Administration has given approval to market Meridian's test for Clostridium difficile.

Meridian, a medical test developer and maker, said it takes less than an hour to run the assay for illumigene C. difficile, a bacterium that can cause diarrhea and colitis.

C. difficile is associated with drug-resistant infections.

In afternoon trading, Meridian stock advanced $1.45, or 8.3 percent, to $18.97 on Tuesday.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading